Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG in Spinocerebellar Ataxia
NCT01350440Phase 2Completed
- Sponsor
- University of South Florida
- Start
- Aug 2011
- Primary completion
- Jul 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of intravenous immunoglobulin G in spinocerebellar ataxia (SCA), sponsored by University of South Florida. Primary endpoint: Scale for the Assessment and Rating of Ataxia at 4 months. Started Aug 2011; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
spinocerebellar ataxia (SCA)
Beyond the preview
Go deeper on NCT01350440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01350440.